As a leading full service CRO, PSI provides the services required to support global clinical trials, offering in-depth therapeutic experience across Phase I-IV clinical programs. We provide you with the expertise that is needed to conduct your clinical trial, whether it is a Phase I study, proof-of-concept or rescuing a pivotal study where enrollment is behind schedule; our goal is to complete your study on time!
For pediatric studies, where competition for patients and complexity of design are leading characteristics, we apply our years of experience and relationships with investigators to manage and support their efforts to meet enrollment goals.
PSI has successfully performed Phase II/III studies in the following pediatric indications:
- Allergic Rhinitis
- ENT Infections
- Atopic Dermatitis
- Neonatal RDS
- Vaccine
- CINV
|
- Arterial Hypertension
- Hepatitis ( HAV, HBV, HCV)
- Diabetes Type I
- Otitis Media
- Pediatric Tumors
|
- Asthma
- Influenza
- Diabetes Type II
- Pneumonia
- Growth Retardation
- PONV
|
PSI employs physicians as full-time monitors and project managers, the majority of whom are board certified specialists, including pediatricians and neonatologists.
Case Study Examples: PONV Clinical Trial
